Event > Conference >
The 22nd International Congress of the European Society of Toxicology In Vitro (ESTIV 2024) will be organised in Prague, Czech Republic, from 3rd to 6th June 2024.
The ESTIV2024 Congress theme is Application of NAMs in Drug Discovery and Drug and Chemical Safety Assessment.
Head to our exhibition stand – #33
Our dedicated team will be available to answer questions and share over a decade of organ-on-a-chip (OOC) expertise with you at ESTIV 2024!
We look forward to introducing you to our PhysioMimix® suite of hardware, consumables, assay protocols and contract research services. Discover how our solutions deliver clinically relevant mechanistic data that enable you to design cost-efficient in vivo studies (using fewer animals) and improve your ability to predict clinical outcomes.
Plus, meet the new game-changing product in our PhysioMimix OOC range of microphysiological systems, the PhysioMimix Single-organ Higher Throughput (HT) System and associated Multi-chip Liver-48 plate.
A Sensitive and Robust Human Liver Microphysiological System for Assessing Drug-Induced Liver Injury
More details coming soon!
Presented by: Dr. Ovidiu Novac, CN Bio
Our Team at ESTIV 2024
Dr Ovidiu Novac is a Senior Scientist at CN Bio and a knowledgeable organ-on-a-chip (OOC) expert. Ovi performed as lead biological scientist in the NASH-in-a-Box project, is a knowledgeable organ-on-a-chip (OOC) expert, and has experience in assessing drug induced liver injury in vitro. Ovi has a background in the developmental stage of pharmaceutical and dermatological formulations and their performance assessment on human skin tissue ex vivo (topical and transdermal), and for strategic planning for further evaluation. During time spent in the pharma industry he contributed to delivering high quality results used for marketing purposes and in regulatory submissions. Ovi holds a BSc in biomaterials and prosthetic technologies and a PhD in chemistry and has been involved in research on controlled drug delivery systems since 2006.